Skip to main content
PMC home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1996 Dec;86(12):1717–1722. doi: 10.2105/ajph.86.12.1717

From genes to public health: the applications of genetic technology in disease prevention. Genetics Working Group.

M J Khoury 1
PMCID: PMC1380723  PMID: 9003127

Abstract

OBJECTIVES: With advances in the Human Genome Project, the implications of genetic technology in disease prevention should be assessed. METHODS: The paradigm suggested in The Future of Public Health--assessment, policy development, and assurance--was used to examine the continuum from genetic technology to public health practice. RESULTS: First, important public health functions are to (1) assess the impact of genes and their interactions with modifiable disease risk factors on the health status of the population and (2) assess the impact and safety of genetic testing on the population. Second, given the many implications of genetic testing, the public health community should participate in policy development related to the timing and use of genetic testing in disease prevention. Third, whenever appropriate, the public health community needs to ensure the development of public health genetics programs (e.g. newborn screening) and evaluate the quality and effectiveness of the use of genetic testing in disease prevention. CONCLUSIONS: Although most current genetic tests are not ready for disease prevention, there is an important role for the public health community in translating genetic technology into disease prevention.

Full text

PDF
1722

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aly A. M., Aledort L. M., Lee T. D., Hoyer L. W. Histocompatibility antigen patterns in haemophilic patients with factor VIII antibodies. Br J Haematol. 1990 Oct;76(2):238–241. doi: 10.1111/j.1365-2141.1990.tb07878.x. [DOI] [PubMed] [Google Scholar]
  2. Andrews L. B., Jaeger A. S. Confidentiality of genetic information in the workplace. Am J Law Med. 1991;17(1-2):75–108. [PubMed] [Google Scholar]
  3. Berkelman R. L., Curran J. W. Epidemiology of HIV infection and AIDS. Epidemiol Rev. 1989;11:222–228. doi: 10.1093/oxfordjournals.epirev.a036038. [DOI] [PubMed] [Google Scholar]
  4. Billings P. R., Beckwith J., Alper J. S. The genetic analysis of human behavior: a new era? Soc Sci Med. 1992 Aug;35(3):227–238. doi: 10.1016/0277-9536(92)90019-m. [DOI] [PubMed] [Google Scholar]
  5. Billings P., Beckwith J. Genetic testing in the workplace: a view from the USA. Trends Genet. 1992 Jun;8(6):198–202. doi: 10.1016/0168-9525(92)90233-t. [DOI] [PubMed] [Google Scholar]
  6. Corder E. H., Saunders A. M., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Small G. W., Roses A. D., Haines J. L., Pericak-Vance M. A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993 Aug 13;261(5123):921–923. doi: 10.1126/science.8346443. [DOI] [PubMed] [Google Scholar]
  7. Daly L. E., Kirke P. N., Molloy A., Weir D. G., Scott J. M. Folate levels and neural tube defects. Implications for prevention. JAMA. 1995 Dec 6;274(21):1698–1702. doi: 10.1001/jama.1995.03530210052030. [DOI] [PubMed] [Google Scholar]
  8. Decker D. Prophylactic mastectomy for familial breast cancer. JAMA. 1993 May 26;269(20):2608–2609. [PubMed] [Google Scholar]
  9. Easton D. F., Ford D., Bishop D. T. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet. 1995 Jan;56(1):265–271. [PMC free article] [PubMed] [Google Scholar]
  10. Futreal P. A., Liu Q., Shattuck-Eidens D., Cochran C., Harshman K., Tavtigian S., Bennett L. M., Haugen-Strano A., Swensen J., Miki Y. BRCA1 mutations in primary breast and ovarian carcinomas. Science. 1994 Oct 7;266(5182):120–122. doi: 10.1126/science.7939630. [DOI] [PubMed] [Google Scholar]
  11. Garver K. L., Garver B. The Human Genome Project and eugenic concerns. Am J Hum Genet. 1994 Jan;54(1):148–158. [PMC free article] [PubMed] [Google Scholar]
  12. Gaston M. H., Verter J. I., Woods G., Pegelow C., Kelleher J., Presbury G., Zarkowsky H., Vichinsky E., Iyer R., Lobel J. S. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med. 1986 Jun 19;314(25):1593–1599. doi: 10.1056/NEJM198606193142501. [DOI] [PubMed] [Google Scholar]
  13. Hoffman E. P. The Evolving Genome Project: current and future impact. Am J Hum Genet. 1994 Jan;54(1):129–136. [PMC free article] [PubMed] [Google Scholar]
  14. Jordan E. The Human Genome Project: where did it come from, where is it going? Am J Hum Genet. 1992 Jul;51(1):1–6. [PMC free article] [PubMed] [Google Scholar]
  15. Kaback M., Lim-Steele J., Dabholkar D., Brown D., Levy N., Zeiger K. Tay-Sachs disease--carrier screening, prenatal diagnosis, and the molecular era. An international perspective, 1970 to 1993. The International TSD Data Collection Network. JAMA. 1993 Nov 17;270(19):2307–2315. [PubMed] [Google Scholar]
  16. Kalow W. The Pennsylvania State University College of Medicine 1990 Bernard B. Brodie Lecture. Pharmacogenetics: past and future. Life Sci. 1990;47(16):1385–1397. doi: 10.1016/0024-3205(90)90517-u. [DOI] [PubMed] [Google Scholar]
  17. Keverne E. B. Molecular genetic approaches to understanding brain development and behaviour. Psychoneuroendocrinology. 1994;19(5-7):407–414. doi: 10.1016/0306-4530(94)90028-0. [DOI] [PubMed] [Google Scholar]
  18. Khoury M. J., Beaty T. H. Applications of the case-control method in genetic epidemiology. Epidemiol Rev. 1994;16(1):134–150. doi: 10.1093/oxfordjournals.epirev.a036139. [DOI] [PubMed] [Google Scholar]
  19. Khoury M. J., Newill C. A., Chase G. A. Epidemiologic evaluation of screening for risk factors: application to genetic screening. Am J Public Health. 1985 Oct;75(10):1204–1208. doi: 10.2105/ajph.75.10.1204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Khoury M. J., Wagener D. K. Epidemiological evaluation of the use of genetics to improve the predictive value of disease risk factors. Am J Hum Genet. 1995 Apr;56(4):835–844. [PMC free article] [PubMed] [Google Scholar]
  21. King M. C., Rowell S., Love S. M. Inherited breast and ovarian cancer. What are the risks? What are the choices? JAMA. 1993 Apr 21;269(15):1975–1980. [PubMed] [Google Scholar]
  22. Leikin S. L., Gallagher D., Kinney T. R., Sloane D., Klug P., Rida W. Mortality in children and adolescents with sickle cell disease. Cooperative Study of Sickle Cell Disease. Pediatrics. 1989 Sep;84(3):500–508. [PubMed] [Google Scholar]
  23. McKusick V. A., Amberger J. S. The morbid anatomy of the human genome: chromosomal location of mutations causing disease (update 1 December 1993). J Med Genet. 1994 Apr;31(4):265–279. doi: 10.1136/jmg.31.4.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Miki Y., Swensen J., Shattuck-Eidens D., Futreal P. A., Harshman K., Tavtigian S., Liu Q., Cochran C., Bennett L. M., Ding W. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994 Oct 7;266(5182):66–71. doi: 10.1126/science.7545954. [DOI] [PubMed] [Google Scholar]
  25. Oakley G. P., Jr, Erickson J. D., Adams M. J., Jr Urgent need to increase folic acid consumption. JAMA. 1995 Dec 6;274(21):1717–1718. [PubMed] [Google Scholar]
  27. Plomin R., Owen M. J., McGuffin P. The genetic basis of complex human behaviors. Science. 1994 Jun 17;264(5166):1733–1739. doi: 10.1126/science.8209254. [DOI] [PubMed] [Google Scholar]
  28. Richards B., Skoletsky J., Shuber A. P., Balfour R., Stern R. C., Dorkin H. L., Parad R. B., Witt D., Klinger K. W. Multiplex PCR amplification from the CFTR gene using DNA prepared from buccal brushes/swabs. Hum Mol Genet. 1993 Feb;2(2):159–163. doi: 10.1093/hmg/2.2.159. [DOI] [PubMed] [Google Scholar]
  29. Salmon R. J., Vilcoq J. R. Cancer du sein après mammectomie sous-cutanée préventive. Presse Med. 1995 Sep 2;24(25):1167–1168. [PubMed] [Google Scholar]
  30. Saunders A. M., Strittmatter W. J., Schmechel D., George-Hyslop P. H., Pericak-Vance M. A., Joo S. H., Rosi B. L., Gusella J. F., Crapper-MacLachlan D. R., Alberts M. J. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993 Aug;43(8):1467–1472. doi: 10.1212/wnl.43.8.1467. [DOI] [PubMed] [Google Scholar]
  31. Schull W. J., Hanis C. L. Genetics and public health in the 1990s. Annu Rev Public Health. 1990;11:105–125. doi: 10.1146/annurev.pu.11.050190.000541. [DOI] [PubMed] [Google Scholar]
  32. Schwaab R., Brackmann H. H., Meyer C., Seehafer J., Kirchgesser M., Haack A., Olek K., Tuddenham E. G., Oldenburg J. Haemophilia A: mutation type determines risk of inhibitor formation. Thromb Haemost. 1995 Dec;74(6):1402–1406. [PubMed] [Google Scholar]
  33. Shohat M., Legum C., Romem Y., Borochowitz Z., Bach G., Goldman B. Down syndrome prevention program in a population with an older maternal age. Obstet Gynecol. 1995 Mar;85(3):368–373. doi: 10.1016/0029-7844(94)00401-X. [DOI] [PubMed] [Google Scholar]
  34. Steere A. C., Dwyer E., Winchester R. Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles. N Engl J Med. 1990 Jul 26;323(4):219–223. doi: 10.1056/NEJM199007263230402. [DOI] [PubMed] [Google Scholar]
  35. Tsai M. S., Tangalos E. G., Petersen R. C., Smith G. E., Schaid D. J., Kokmen E., Ivnik R. J., Thibodeau S. N. Apolipoprotein E: risk factor for Alzheimer disease. Am J Hum Genet. 1994 Apr;54(4):643–649. [PMC free article] [PubMed] [Google Scholar]
  36. Vineis P., Schulte P. A. Scientific and ethical aspects of genetic screening of workers for cancer risk: the case of the N-acetyltransferase phenotype. J Clin Epidemiol. 1995 Feb;48(2):189–197. doi: 10.1016/0895-4356(94)00131-9. [DOI] [PubMed] [Google Scholar]
  37. Wald N. J., Densem J. W., Smith D., Klee G. G. Four-marker serum screening for Down's syndrome. Prenat Diagn. 1994 Aug;14(8):707–716. doi: 10.1002/pd.1970140810. [DOI] [PubMed] [Google Scholar]
  38. Watson J. D. The human genome project: past, present, and future. Science. 1990 Apr 6;248(4951):44–49. doi: 10.1126/science.2181665. [DOI] [PubMed] [Google Scholar]
  39. Weyand C. M., Hicok K. C., Conn D. L., Goronzy J. J. The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Ann Intern Med. 1992 Nov 15;117(10):801–806. doi: 10.7326/0003-4819-117-10-801. [DOI] [PubMed] [Google Scholar]
  40. Wordsworth B. P., Bell J. I. The immunogenetics of rheumatoid arthritis. Springer Semin Immunopathol. 1992;14(1):59–78. doi: 10.1007/BF00197132. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES